ProPhase Labs, Inc.

NasdaqCM:PRPH Stock Report

Market Cap: US$17.2m

ProPhase Labs Management

Management criteria checks 1/4

ProPhase Labs' CEO is Ted Karkus, appointed in Jun 2009, has a tenure of 15.5 years. total yearly compensation is $3.37M, comprised of 20% salary and 80% bonuses, including company stock and options. directly owns 13.47% of the company’s shares, worth $2.31M. The average tenure of the management team and the board of directors is 0.9 years and 15.5 years respectively.

Key information

Ted Karkus

Chief executive officer

US$3.4m

Total compensation

CEO salary percentage20.0%
CEO tenure15.5yrs
CEO ownership13.5%
Management average tenureless than a year
Board average tenure15.5yrs

Recent management updates

Recent updates

Investors Give ProPhase Labs, Inc. (NASDAQ:PRPH) Shares A 65% Hiding

Nov 09
Investors Give ProPhase Labs, Inc. (NASDAQ:PRPH) Shares A 65% Hiding

It's Down 65% But ProPhase Labs, Inc. (NASDAQ:PRPH) Could Be Riskier Than It Looks

Nov 09
It's Down 65% But ProPhase Labs, Inc. (NASDAQ:PRPH) Could Be Riskier Than It Looks

Market Cool On ProPhase Labs, Inc.'s (NASDAQ:PRPH) Revenues Pushing Shares 26% Lower

Jul 03
Market Cool On ProPhase Labs, Inc.'s (NASDAQ:PRPH) Revenues Pushing Shares 26% Lower

Does This Valuation Of ProPhase Labs, Inc. (NASDAQ:PRPH) Imply Investors Are Overpaying?

Mar 04
Does This Valuation Of ProPhase Labs, Inc. (NASDAQ:PRPH) Imply Investors Are Overpaying?

ProPhase Labs, Inc.'s (NASDAQ:PRPH) Business And Shares Still Trailing The Industry

Jan 09
ProPhase Labs, Inc.'s (NASDAQ:PRPH) Business And Shares Still Trailing The Industry

ProPhase Labs, Inc. (NASDAQ:PRPH) Shares Could Be 28% Above Their Intrinsic Value Estimate

Sep 21
ProPhase Labs, Inc. (NASDAQ:PRPH) Shares Could Be 28% Above Their Intrinsic Value Estimate

Here's Why ProPhase Labs (NASDAQ:PRPH) Can Afford Some Debt

Aug 11
Here's Why ProPhase Labs (NASDAQ:PRPH) Can Afford Some Debt

We Ran A Stock Scan For Earnings Growth And ProPhase Labs (NASDAQ:PRPH) Passed With Ease

Apr 07
We Ran A Stock Scan For Earnings Growth And ProPhase Labs (NASDAQ:PRPH) Passed With Ease

ProPhase Labs (NASDAQ:PRPH) Seems To Use Debt Quite Sensibly

Jan 24
ProPhase Labs (NASDAQ:PRPH) Seems To Use Debt Quite Sensibly

ProPhase Labs: Small Cap Stock With Strong Fundamentals And Growth Potential

Oct 13

ProPhase Labs Q2 2022 Earnings Preview

Aug 10

We Think ProPhase Labs (NASDAQ:PRPH) Can Stay On Top Of Its Debt

Jul 26
We Think ProPhase Labs (NASDAQ:PRPH) Can Stay On Top Of Its Debt

ProPhase Labs to license two investigational cancer compounds from Global BioLife

Jul 21

ProPhase Labs: A Stellar Quarter And Another Special Dividend

May 16

CEO Compensation Analysis

How has Ted Karkus's remuneration changed compared to ProPhase Labs's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$28m

Jun 30 2024n/an/a

-US$26m

Mar 31 2024n/an/a

-US$24m

Dec 31 2023US$3mUS$675k

-US$17m

Sep 30 2023n/an/a

-US$10m

Jun 30 2023n/an/a

-US$4m

Mar 31 2023n/an/a

US$7m

Dec 31 2022US$902kUS$675k

US$18m

Sep 30 2022n/an/a

US$31m

Jun 30 2022n/an/a

US$27m

Mar 31 2022n/an/a

US$18m

Dec 31 2021US$941kUS$590k

US$6m

Sep 30 2021n/an/a

-US$5m

Jun 30 2021n/an/a

-US$2m

Mar 31 2021n/an/a

-US$460k

Dec 31 2020US$445kUS$125k

-US$2m

Sep 30 2020n/an/a

-US$2m

Jun 30 2020n/an/a

-US$2m

Mar 31 2020n/an/a

-US$3m

Dec 31 2019US$249kUS$125k

-US$3m

Sep 30 2019n/an/a

-US$3m

Jun 30 2019n/an/a

-US$4m

Mar 31 2019n/an/a

-US$3m

Dec 31 2018US$2mUS$210k

-US$2m

Compensation vs Market: Ted's total compensation ($USD3.37M) is above average for companies of similar size in the US market ($USD649.63K).

Compensation vs Earnings: Ted's compensation has increased whilst the company is unprofitable.

CEO

Ted Karkus (65 yo)

15.5yrs

Tenure

US$3,367,200

Compensation

Mr. Ted William Karkus has served as the Chief Executive Officer of ProPhase Labs, Inc. since June 2009. Mr. Karkus founded 2001 Forrester Financial LLC and served as its Managing Member. He is a Managemen...

Leadership Team

NamePositionTenureCompensationOwnership
Ted Karkus
Chairman & CEO15.5yrsUS$3.37m13.47%
$ 2.3m
Sergio Miralles
Executive VP & Chief Information Officerless than a yearno datano data
Kamal Obbad
Senior VP and Director of Sales & Marketing - Nebula Genomics1.9yrsno datano data
Jason Karkus
President of Nebula Genomicsless than a yearno datano data
Lance Bisesar
Corporate Controllerless than a yearno datano data

0.9yrs

Average Tenure

Experienced Management: PRPH's management team is not considered experienced ( 0.9 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Ted Karkus
Chairman & CEO15.5yrsUS$3.37m13.47%
$ 2.3m
Louis Gleckel
Independent Director15.5yrsUS$223.00k0.43%
$ 74.7k
Warren Hirsch
Independent Director5.6yrsUS$223.00k0%
$ 0

15.5yrs

Average Tenure

66yo

Average Age

Experienced Board: PRPH's board of directors are seasoned and experienced ( 15.5 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/31 09:05
End of Day Share Price 2024/12/31 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

ProPhase Labs, Inc. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hunter DiamondDiamond Equity Research LLC
Ashok KumarThinkEquity LLC